1564-1565 / 2437
ASCO 2017: Abstract #182373
A Phase II Prospective Study of Selumetinib in Children
with Recurrent or Refractory Low-grade Glioma (LGG):
A Pediatric Brain Tumor Consortium (PBTC) Study
Jason Fangusaro, MD
Pediatric Brain Tumor Consortium (PBTC)
Ann & Robert H. Lurie Children’s Hospital of Chicago
Associate Professor of Pediatrics
Northwestern University Feinberg School of Medicine